VYNE Therapeutics Inc (VYNE) USD0.0001

Sell:$2.44Buy:$2.85$0.27 (8.94%)

Prices delayed by at least 15 minutes
Sell:$2.44
Buy:$2.85
Change:$0.27 (8.94%)
Prices delayed by at least 15 minutes
Sell:$2.44
Buy:$2.85
Change:$0.27 (8.94%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
31 December 2024
David DomzalskiPresident/CEO
Sell
Tax related
24,536$3.35$82,195.60476,061
31 December 2024
Mutya HarschChief Legal/Compliance Officer
Sell
Tax related
4,697$3.35$15,734.95144,329
31 December 2024
Iain StuartChief Level Officer
Sell
Tax related
4,857$3.35$16,270.95128,637
31 December 2024
Tyler ZerondaCFO
Sell
Tax related
4,675$3.35$15,661.25126,892
30 September 2024
David DomzalskiPresident/CEO
Sell
Tax related
685$1.88$1,287.80496,696
30 September 2024
Mutya HarschChief Legal/Compliance Officer
Sell
Tax related
105$1.88$197.40149,026
30 September 2024
Iain StuartChief Level Officer
Sell
Tax related
109$1.88$204.92133,494
30 September 2024
Tyler ZerondaCFO
Sell
Tax related
84$1.88$157.92131,567
1 July 2024
David DomzalskiPresident/CEO
Sell
Tax related
935$1.92$1,795.20497,654
1 July 2024
Mutya HarschChief Legal/Compliance Officer
Sell
Tax related
143$1.92$274.56149,131

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
31 December 2024
David DomzalskiPresident/CEO
Sell
Tax related
24,536$3.35$82,195.60476,061
31 December 2024
Iain StuartChief Level Officer
Sell
Tax related
4,857$3.35$16,270.95128,637
31 December 2024
Mutya HarschChief Legal/Compliance Officer
Sell
Tax related
4,697$3.35$15,734.95144,329
31 December 2024
Tyler ZerondaCFO
Sell
Tax related
4,675$3.35$15,661.25126,892
1 April 2024
David DomzalskiPresident/CEO
Sell
Tax related
1,004$3.08$3,092.32494,160

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.